Full text
=========

Objective
---------

To evaluate the efficacy of NINMV in cardiac surgical patients. In order to verify if, beside already established advantages in critical care patients \[[@B1]\] (less intubation related complications, minor discomfort for patients and less need for sedation), NINMV can be useful in managing the weaning process in the postoperative cardiac surgical course.

Design
------

Retrospective survey. We used NINMV with two indications: (1) patients with unexpected postoperative respiratory failure requiring reintubation; (2) patients extubated early and with incomplete postoperative recovery of cardiorespiratory stability.

Setting
-------

Five bed intensive care unit at a cardiothoracic surgery centre.

Patients
--------

Twenty NINMV patients representing 4.1% of the 484 patients operated on from October 1998 to September 1999 in our centre. Urgent surgery occurred in 12% of cases, emergency surgery in 4.75% of cases. Overall in-hospital mortality was 14/484 (2.2%).

Interventions
-------------

We use a nasal or facial mask (Respironics Inc., Murrysville, Pennsylvania, USA) connected to a Servo Ventilator 300 (Siemens-Elema, Sweden). Patients were ventilated by Pressure Support (10--15 cmH~2~0) with PEEP (5--8 cmH~2~O). Intermittent periods of NINMV were alternated with periods of spontaneous breathing accordingly to patients needs. Sedation was obtained by Remifentanyl infusion in the range 0.03--0.07 γ kg^-1^min^-1^.

Measurements and main results
-----------------------------

Twenty patients. were treated by NINMV (two with indication 1 and 18 patients. with indication 2). The two patients with indication 1 were successfully weaned and discharged. None of the other 484 patients in this series needed reintubation.

Table [1](#T1){ref-type="table"} characterises patients with indication 2 and summarises results.

Only 3 patients had to be reintubated (n°3 for unexpected haematological complication, n°8 for psychotic disturbances, n°18 failed full haemodynamic recovery).

Conclusions
-----------

NINMV patients with indication 2 were weaned from respiratory support earlier than usual during a complicated postoperative course. The good results of our series suggest that NINMV indication 2 can be viewed as a weaning model. The most severe forms of circulatory impairment and the non-collaborative patient seem to be, accordingly to literature, exclusion criteria. A wider study would better precise inclusion and exclusion criteria in cardiac surgical patients.

  pt   age   Pathology                                 Haemodynamic support   NINMV days   Outcome
  ---- ----- ----------------------------------------- ---------------------- ------------ ---------
  1    19    Ascend. Aorta Replacement, AR,MR          high                   3            W
  2    81    MR, Pulm. Hypert., postop renal failure   high                   1            W
  3    72    CABG, postop acute leukaemia              high                   3            R
  4    64    CABG, postop redo CABG                    high                   2            W
  5    62    CABG, postop PTCA                         low                    2            W
  6    55    AR, MR, Pulm Hypert.                      high                   3            W
  7    74    MR,CABG,cardiogenic shock                 high                   5            W
  8    71    AR,CABG, postop psycomot. agitation       low                    4            R
  9    60    MR, Pulm Hypert                           medium                 2            W
  10   77    CABG, COPD                                medium                 1            W
  11   61    CABG, Pulm. Fibrosis                      medium                 2            W
  12   75    MR                                        medium                 2            W
  13   70    CABG, obesity                             low                    1            W
  14   71    CABG,postop renal failure                 high                   3            W
  15   65    AR,pulm Hypert                            high                   1            W
  16   77    CABG                                      low                    1            W
  17   42    AR,CABG                                   medium                 2            W
  18   77    CABG, Hypertrophic. Myocard.              medium                 8            R

AR=aortic replacement, MR=mitral replacement, CABG=coronary artery bypass grafting, COPD=chronic obstructive pulmonary disease, PTCA=percutaneous coronary angioplasty, W=weaned, R=reintubated.
